Loading
Nobody knows what a cancer trial should cost because budgets are secret. Publishing anonymised cost per patient by trial type would expose waste and let funders set targets.
Sponsors and sites contribute anonymised per-patient cost data by phase, design and procedure to an independent benchmark (as hospitals do for procedure costs), broken down into drug, monitoring, imaging, data management and site payments. Funders set cost-per-patient targets for public trials and require justification above the benchmark.
Shares Funding follows fashion, not burden, Cancer Research UK, National Cancer Institute (NIH).
Shares Funding follows fashion, not burden, Cancer Research UK, National Cancer Institute (NIH).
Shares Funding follows fashion, not burden, Trial design, endpoints and cost, National Cancer Institute (NIH).
Shares Cancer Research UK, Trial design, endpoints and cost, National Cancer Institute (NIH).
Shares Funding follows fashion, not burden, National Cancer Institute (NIH).
Shares Funding follows fashion, not burden, Cancer Research UK, National Cancer Institute (NIH).
Shares Funding follows fashion, not burden, Cancer Research UK, National Cancer Institute (NIH).